×
MariMed Goodwill and Intangible Assets 2012-2024 | MRMD
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
MariMed goodwill and intangible assets from 2012 to 2024. Goodwill and intangible assets can be defined as the sum of all intangible asset fields
View More
MariMed Goodwill and Intangible Assets 2012-2024 | MRMD
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
MariMed goodwill and intangible assets from 2012 to 2024. Goodwill and intangible assets can be defined as the sum of all intangible asset fields
Related Stocks
Company Name
Market
Cap
Abbott Laboratories (ABT)
$203.2B
Stryker (SYK)
$148.2B
Boston Scientific (BSX)
$133.1B
EssilorLuxottica (ESLOY)
$113.5B
Medtronic (MDT)
$109B
Haleon (HLN)
$42.9B
Lonza Group Ag (LZAGY)
$42.1B
GE HealthCare Technologies (GEHC)
$37.7B
ResMed (RMD)
$35B
Terumo (TRUMY)
$29.2B
Koninklijke Philips (PHG)
$24.4B
Zimmer Biomet Holdings (ZBH)
$22.1B
Insulet (PODD)
$18.4B
Baxter (BAX)
$16.6B
Smith & Nephew SNATS (SNN)
$11.2B
BellRing Brands (BRBR)
$9.5B
Bio-Rad Laboratories (BIO)
$9B
Demant (WILYY)
$8.3B
Lantheus Holdings (LNTH)
$5.5B
TG Therapeutics (TGTX)
$4.7B
Haemonetics (HAE)
$4.3B
ICU Medical (ICUI)
$4.2B
Prestige Consumer Healthcare (PBH)
$4.1B
Perrigo (PRGO)
$3.7B
Envista Holdings (NVST)
$3.5B
Neogen (NEOG)
$3.3B
Agios Pharmaceuticals (AGIO)
$3.1B
Shandong Weigao Medical Polymer (SHWGF)
$3B
GN Store Nord (GNNDY)
$2.8B
QuidelOrtho (QDEL)
$2.6B